Publications
- PCSK9 Inhibitors in Real-world Practice: Analysis of Data from 314 Patients and 2 Years of Experience in a Center of Preventive Cardiology2022 | First Faculty of Medicine
- Multiple risk factors intervention in patients with type 2 diabetes: current state and perspectives2020 | First Faculty of Medicine
- LIPIcontrol 2 what has changed after 3 years2020 | First Faculty of Medicine
- Fixed-dose combination of rosuvastatin and ezetimibe2020 | First Faculty of Medicine
- The significance and treatment of dyslipidaemia in young adults2018 | First Faculty of Medicine
- Cardiovascular risk in myositis patients compared with the general population2023 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Genetic risk score in patients with the APOE2/E2 genotype as a predictor of familial dysbetalipoproteinemia2023 | First Faculty of Medicine, Faculty of Science
- Low LDL-C goal attainment in patients at very high cardiovascular risk due to lacking observance of the guidelines on dyslipidaemias2023 | First Faculty of Medicine
- Dyslipidemia - the known unknown2023 | First Faculty of Medicine
- The frequency of, and predisposing risk factors for, ciprofloxacin-induced neuro-psychiatric adverse drug reactions2023 | First Faculty of Medicine
Loading network view...